Controlled release formulation of clarithromycin or tinidazol

Details Controlled release formulation of clarithromycin or tinidazol Controlled release formulation of clarithromycin or tinidazol

A - Human Necessities

61

K

A61K 9/20 (2006.01) A61K 31/7048 (2006.01)

Patent

CA 2458776

The present invention relates to a controlled release pharmaceutical composition comprising amounts ranging from about 0.1 to about 4.5% w/w, of one or more of rate controlling cellulosic ether polymers.

L'invention concerne une composition pharmaceutique à libération contrôlée comprenant des quantités d'environ 0,1 à environ 4,5 % en poids d'un ou de plusieurs polymères d'éther cellulosiques de régulation de débit.

Affiliated with

Also associated with

Rating

Controlled release formulation of clarithromycin or tinidazol does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Controlled release formulation of clarithromycin or tinidazol, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled release formulation of clarithromycin or tinidazol will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1720132